These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Strontium ranelate: a new paradigm in the treatment of osteoporosis. Reginster JY; Deroisy R; Jupsin I Drugs Today (Barc); 2003 Feb; 39(2):89-101. PubMed ID: 12698204 [TBL] [Abstract][Full Text] [Related]
6. Strontium ranelate for the management of osteoporosis. Lam S; Zouzias K Consult Pharm; 2008 Jul; 23(7):531-7. PubMed ID: 18764671 [TBL] [Abstract][Full Text] [Related]
7. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. Meunier PJ; Roux C; Seeman E; Ortolani S; Badurski JE; Spector TD; Cannata J; Balogh A; Lemmel EM; Pors-Nielsen S; Rizzoli R; Genant HK; Reginster JY N Engl J Med; 2004 Jan; 350(5):459-68. PubMed ID: 14749454 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. Kaufman JM; Audran M; Bianchi G; Braga V; Diaz-Curiel M; Francis RM; Goemaere S; Josse R; Palacios S; Ringe JD; Felsenberg D; Boonen S J Clin Endocrinol Metab; 2013 Feb; 98(2):592-601. PubMed ID: 23341486 [TBL] [Abstract][Full Text] [Related]
10. Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis. Reginster JY; Kaufman JM; Goemaere S; Devogelaer JP; Benhamou CL; Felsenberg D; Diaz-Curiel M; Brandi ML; Badurski J; Wark J; Balogh A; Bruyère O; Roux C Osteoporos Int; 2012 Mar; 23(3):1115-22. PubMed ID: 22124575 [TBL] [Abstract][Full Text] [Related]
11. Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. Meunier PJ; Roux C; Ortolani S; Diaz-Curiel M; Compston J; Marquis P; Cormier C; Isaia G; Badurski J; Wark JD; Collette J; Reginster JY Osteoporos Int; 2009 Oct; 20(10):1663-73. PubMed ID: 19153678 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of 2 g/day of strontium ranelate in Asian women with postmenopausal osteoporosis. Liu JM; Wai-Chee Kung A; Pheng CS; Zhu HM; Zhang ZL; Wu YY; Xu L; Meng XW; Huang ML; Chung LP; Hussain NH; Sufian SS; Chen JL Bone; 2009 Sep; 45(3):460-5. PubMed ID: 19464401 [TBL] [Abstract][Full Text] [Related]
13. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789 [TBL] [Abstract][Full Text] [Related]
14. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors. Roux C; Reginster JY; Fechtenbaum J; Kolta S; Sawicki A; Tulassay Z; Luisetto G; Padrino JM; Doyle D; Prince R; Fardellone P; Sorensen OH; Meunier PJ J Bone Miner Res; 2006 Apr; 21(4):536-42. PubMed ID: 16598373 [TBL] [Abstract][Full Text] [Related]
15. Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis. Meunier PJ; Reginster JY Osteoporos Int; 2003; 14 Suppl 3():S66-76. PubMed ID: 12730769 [TBL] [Abstract][Full Text] [Related]
16. Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover. Collette J; Bruyère O; Kaufman JM; Lorenc R; Felsenberg D; Spector TD; Diaz-Curiel M; Boonen S; Reginster JY Osteoporos Int; 2010 Feb; 21(2):233-41. PubMed ID: 19436941 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive therapy in osteoporosis using a single drug: from ADFR to strontium ranelate. Manette C; Collette J; Sarlet N; Tancredi A; Zegels B; Reginster JY Curr Med Chem; 2006; 13(13):1585-90. PubMed ID: 16787205 [TBL] [Abstract][Full Text] [Related]
18. Strontium ranelate: a new paradigm in the treatment of osteoporosis. Reginster JY; Lecart MP; Deroisy R; Lousberg C Expert Opin Investig Drugs; 2004 Jul; 13(7):857-64. PubMed ID: 15212623 [TBL] [Abstract][Full Text] [Related]
19. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. Reginster JY; Seeman E; De Vernejoul MC; Adami S; Compston J; Phenekos C; Devogelaer JP; Curiel MD; Sawicki A; Goemaere S; Sorensen OH; Felsenberg D; Meunier PJ J Clin Endocrinol Metab; 2005 May; 90(5):2816-22. PubMed ID: 15728210 [TBL] [Abstract][Full Text] [Related]
20. The effects of strontium ranelate in Asian women with postmenopausal osteoporosis. Hwang JS; Chen JF; Yang TS; Wu DJ; Tsai KS; Ho C; Wu CH; Su SL; Wang CJ; Tu ST Calcif Tissue Int; 2008 Nov; 83(5):308-14. PubMed ID: 18843436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]